Literature DB >> 2303828

Frontal lobe dementia and motor neuron disease.

D Neary1, J S Snowden, D M Mann, B Northen, P J Goulding, N Macdermott.   

Abstract

Four patients are described, in whom a profound and rapidly progressive dementia occurred in association with clinical features of motor neuron disease. The pattern of dementia indicated impaired frontal lobe function, confirmed by reduced tracer uptake in the frontal lobes on single photon emission computed tomography (SPECT). Pathological examination of the brains of two patients revealed frontal-lobe atrophy, with mild gliosis and spongiform change. The spinal cord changes were consistent with motor neuron disease. The clinical picture and pathological findings resembled those of dementia of frontal-lobe type and were distinct from those of Alzheimer's disease. The findings have implications for the understanding of the spectrum of non-Alzheimer forms of primary degenerative dementia.

Entities:  

Mesh:

Year:  1990        PMID: 2303828      PMCID: PMC1014093          DOI: 10.1136/jnnp.53.1.23

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Familial amyotrophic lateral sclerosis with dementia: a second canadian family.

Authors:  L Pinsky; M H Finlayson; I Libman; B H Scott
Journal:  Clin Genet       Date:  1975-03       Impact factor: 4.438

2.  Normative data and screening power of a shortened version of the Token Test.

Authors:  E De Renzi; P Faglioni
Journal:  Cortex       Date:  1978-03       Impact factor: 4.027

3.  Design fluency: the invention of nonsense drawings after focal cortical lesions.

Authors:  M Jones-Gotman; B Milner
Journal:  Neuropsychologia       Date:  1977       Impact factor: 3.139

4.  The involvement of the frontal lobes in cognitive estimation.

Authors:  T Shallice; M E Evans
Journal:  Cortex       Date:  1978-06       Impact factor: 4.027

5.  Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test.

Authors:  H E Nelson; A O'Connell
Journal:  Cortex       Date:  1978-06       Impact factor: 4.027

6.  Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases.

Authors:  Y Mitsuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

7.  Presenile dementia with motor neuron disease in Japan. A new entity?

Authors:  Y Mitsuyama; S Takamiya
Journal:  Arch Neurol       Date:  1979-09

8.  [Association of Pick's disease and amyotrophic lateral sclerosis. Pathological study of one case and review of the literature (author's transl)].

Authors:  S Brion; A Psimaras; J F Chevalier; J Plas; G Massé; O Jatteau
Journal:  Encephale       Date:  1980       Impact factor: 1.291

9.  Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease.

Authors:  A M Salazar; C L Masters; D C Gajdusek; C J Gibbs
Journal:  Ann Neurol       Date:  1983-07       Impact factor: 10.422

10.  Classic amyotrophic lateral sclerosis with dementia.

Authors:  J Wikström; A Paetau; J Palo; R Sulkava; M Haltia
Journal:  Arch Neurol       Date:  1982-11
View more
  81 in total

Review 1.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 2.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

3.  Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease.

Authors:  K Okamoto; N Murakami; H Kusaka; M Yoshida; Y Hashizume; Y Nakazato; E Matsubara; S Hirai
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

Review 4.  Motor neuron disease.

Authors:  M Swash
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

5.  When laughing is no joking matter.

Authors:  Roy Yaari; Helle Brand; James D Seward; Anna D Burke; Adam S Fleisher; Jan Dougherty; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2011

6.  Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography.

Authors:  P Goulding; A Burjan; R Smith; R Lawson; J Snowden; B Northen; D Neary; H Testa
Journal:  Eur J Nucl Med       Date:  1990

Review 7.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

8.  Signs of impaired selective attention in patients with amyotrophic lateral sclerosis.

Authors:  Elmar H Pinkhardt; Reinhart Jürgens; Wolfgang Becker; Matthias Mölle; Jan Born; Albert C Ludolph; Herbert Schreiber
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

9.  Frontotemporal dementia with a C9ORF72 expansion in a Swedish family: clinical and neuropathological characteristics.

Authors:  Maria Landqvist Waldö; Lars Gustafson; Karin Nilsson; Bryan J Traynor; Alan E Renton; Elisabet Englund; Ulla Passant
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

10.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Authors:  Nigel J Cairns; Eileen H Bigio; Ian R A Mackenzie; Manuela Neumann; Virginia M-Y Lee; Kimmo J Hatanpaa; Charles L White; Julie A Schneider; Lea Tenenholz Grinberg; Glenda Halliday; Charles Duyckaerts; James S Lowe; Ida E Holm; Markus Tolnay; Koichi Okamoto; Hideaki Yokoo; Shigeo Murayama; John Woulfe; David G Munoz; Dennis W Dickson; Paul G Ince; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-06-20       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.